Stephen F. Mahoney - 03 Mar 2026 Form 4/A - Amendment Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role: President and CEO, Director
Signature: /s/Jennifer Tousignant, Attorney-in-fact
Issuer symbol: VRDN
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 09 Mar 2026, 19:35:08 UTC
Date Of Original Report: 04 Mar 2026
Previous filing: 04 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mahoney Stephen F.	President and CEO, Director	C/O VIRIDIAN THERAPEUTICS, INC., 221 CRESCENT STREET, SUITE 103A, WALTHAM	/s/Jennifer Tousignant, Attorney-in-fact	09 Mar 2026	0001741389

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VRDN	Common Stock	Tax liability		-7,408	-18%	$30.19^*	33,349	03 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment corrects the number of shares and price sold to cover taxes on the initial Form 4 filed on March 4, 2026, as well as the resulting total number of shares beneficially owned following all transactions reported in the initial Form 4.